Six years' experience with screening of a diethylstilbestrol-exposed population

C. E. Mangan, R. L. Giuntoli, T. V. Sedlacek, T. Rocereto, E. Rubin, M. Burtnett, J. J. Mikuta

Research output: Contribution to journalArticle

Abstract

The physician population delivering obstetric care in Philadelphia between 1950 and 1970 was contacted to ascertain their use of diethylstilbestrol (DES) during pregnancy. Of the 31.8% of the physicians who responded to the questionnaire, 71.8% used DES during pregnancy and 12.7% desired assistance in review of their records. During the 6 years from the initial survey, 830 young women exposed to DES in utero were periodically screened for cervicovaginal abnormalities and clear cell adenocarcinoma. Of these 830 patients 61.7% were found to have cervicovaginal abnormalities, and 65.9% of the patients showed either adenosis or evidence of the prior existence of vaginal adenosis. Eight patients were treated for clear cell adenocarcinoma. Two cases were detected while asymptomatic. Seven of the patients are living with no evidence of cancer, and two of these have survived over 5 years.

Original languageEnglish (US)
Pages (from-to)860-865
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume134
Issue number8
StatePublished - Aug 15 1979
Externally publishedYes

Fingerprint

Diethylstilbestrol
Clear Cell Adenocarcinoma
Population
Physicians
Pregnancy
Obstetrics
Neoplasms
Surveys and Questionnaires

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Mangan, C. E., Giuntoli, R. L., Sedlacek, T. V., Rocereto, T., Rubin, E., Burtnett, M., & Mikuta, J. J. (1979). Six years' experience with screening of a diethylstilbestrol-exposed population. American Journal of Obstetrics and Gynecology, 134(8), 860-865.

Six years' experience with screening of a diethylstilbestrol-exposed population. / Mangan, C. E.; Giuntoli, R. L.; Sedlacek, T. V.; Rocereto, T.; Rubin, E.; Burtnett, M.; Mikuta, J. J.

In: American Journal of Obstetrics and Gynecology, Vol. 134, No. 8, 15.08.1979, p. 860-865.

Research output: Contribution to journalArticle

Mangan, CE, Giuntoli, RL, Sedlacek, TV, Rocereto, T, Rubin, E, Burtnett, M & Mikuta, JJ 1979, 'Six years' experience with screening of a diethylstilbestrol-exposed population', American Journal of Obstetrics and Gynecology, vol. 134, no. 8, pp. 860-865.
Mangan CE, Giuntoli RL, Sedlacek TV, Rocereto T, Rubin E, Burtnett M et al. Six years' experience with screening of a diethylstilbestrol-exposed population. American Journal of Obstetrics and Gynecology. 1979 Aug 15;134(8):860-865.
Mangan, C. E. ; Giuntoli, R. L. ; Sedlacek, T. V. ; Rocereto, T. ; Rubin, E. ; Burtnett, M. ; Mikuta, J. J. / Six years' experience with screening of a diethylstilbestrol-exposed population. In: American Journal of Obstetrics and Gynecology. 1979 ; Vol. 134, No. 8. pp. 860-865.
@article{67ae8dbc349f46e68fb108675e787b77,
title = "Six years' experience with screening of a diethylstilbestrol-exposed population",
abstract = "The physician population delivering obstetric care in Philadelphia between 1950 and 1970 was contacted to ascertain their use of diethylstilbestrol (DES) during pregnancy. Of the 31.8{\%} of the physicians who responded to the questionnaire, 71.8{\%} used DES during pregnancy and 12.7{\%} desired assistance in review of their records. During the 6 years from the initial survey, 830 young women exposed to DES in utero were periodically screened for cervicovaginal abnormalities and clear cell adenocarcinoma. Of these 830 patients 61.7{\%} were found to have cervicovaginal abnormalities, and 65.9{\%} of the patients showed either adenosis or evidence of the prior existence of vaginal adenosis. Eight patients were treated for clear cell adenocarcinoma. Two cases were detected while asymptomatic. Seven of the patients are living with no evidence of cancer, and two of these have survived over 5 years.",
author = "Mangan, {C. E.} and Giuntoli, {R. L.} and Sedlacek, {T. V.} and T. Rocereto and E. Rubin and M. Burtnett and Mikuta, {J. J.}",
year = "1979",
month = "8",
day = "15",
language = "English (US)",
volume = "134",
pages = "860--865",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "8",

}

TY - JOUR

T1 - Six years' experience with screening of a diethylstilbestrol-exposed population

AU - Mangan, C. E.

AU - Giuntoli, R. L.

AU - Sedlacek, T. V.

AU - Rocereto, T.

AU - Rubin, E.

AU - Burtnett, M.

AU - Mikuta, J. J.

PY - 1979/8/15

Y1 - 1979/8/15

N2 - The physician population delivering obstetric care in Philadelphia between 1950 and 1970 was contacted to ascertain their use of diethylstilbestrol (DES) during pregnancy. Of the 31.8% of the physicians who responded to the questionnaire, 71.8% used DES during pregnancy and 12.7% desired assistance in review of their records. During the 6 years from the initial survey, 830 young women exposed to DES in utero were periodically screened for cervicovaginal abnormalities and clear cell adenocarcinoma. Of these 830 patients 61.7% were found to have cervicovaginal abnormalities, and 65.9% of the patients showed either adenosis or evidence of the prior existence of vaginal adenosis. Eight patients were treated for clear cell adenocarcinoma. Two cases were detected while asymptomatic. Seven of the patients are living with no evidence of cancer, and two of these have survived over 5 years.

AB - The physician population delivering obstetric care in Philadelphia between 1950 and 1970 was contacted to ascertain their use of diethylstilbestrol (DES) during pregnancy. Of the 31.8% of the physicians who responded to the questionnaire, 71.8% used DES during pregnancy and 12.7% desired assistance in review of their records. During the 6 years from the initial survey, 830 young women exposed to DES in utero were periodically screened for cervicovaginal abnormalities and clear cell adenocarcinoma. Of these 830 patients 61.7% were found to have cervicovaginal abnormalities, and 65.9% of the patients showed either adenosis or evidence of the prior existence of vaginal adenosis. Eight patients were treated for clear cell adenocarcinoma. Two cases were detected while asymptomatic. Seven of the patients are living with no evidence of cancer, and two of these have survived over 5 years.

UR - http://www.scopus.com/inward/record.url?scp=0018423740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018423740&partnerID=8YFLogxK

M3 - Article

C2 - 463989

AN - SCOPUS:0018423740

VL - 134

SP - 860

EP - 865

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 8

ER -